| # | Drug | Count |
|---|---|---|
| 0 | LEVETIRACETAM | 13 |
| 1 | RITONAVIR | 13 |
| 2 | VENETOCLAX | 13 |
| 3 | DARUNAVIR | 11 |
| 4 | LEVETIRACETAM IN SODIUM CHLORIDE | 11 |
| 5 | LEVETIRACETAM INJECTION | 11 |
| 6 | LEVETIRACETAM ORAL | 11 |
| 7 | LAMOTRIGINE | 10 |
| 8 | DIAZEPAM | 9 |
| 9 | LAMOTIRIGINE | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PIRTOBRUTINIB | 5 | 0.0051 |
| 1 | SODIUM CARBONATE | 1 | 0.0043 |
| 2 | DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE | 3 | 0.0017 |
| 3 | ZANUBRUTINIB | 6 | 0.0013 |
| 4 | IBRITUMOMAB TIUXETAN | 2 | 0.0013 |
| 5 | MECASERMIN | 1 | 0.0012 |
| 6 | LOMUSTINE | 3 | 0.0012 |
| 7 | DARUNAVIR | 11 | 0.0007 |
| 8 | BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B | 1 | 0.0006 |
| 9 | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | BCL-2 Inhibitor [EPC] | 13 |
| 1 | Cytochrome P450 3A Inhibitor [EPC] | 13 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 13 |
| 3 | Protease Inhibitor [EPC] | 13 |
| 4 | Benzodiazepine [EPC] | 12 |
| 5 | Alkylating Drug [EPC] | 11 |
| 6 | Mood Stabilizer [EPC] | 11 |
| 7 | Anti-epileptic Agent [EPC] | 10 |
| 8 | Corticosteroid [EPC] | 10 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Protease Inhibitor [EPC] | 13 | 0.0003 |
| 1 | Cytochrome P450 3A Inhibitor [EPC] | 13 | 0.0002 |
| 2 | BCL-2 Inhibitor [EPC] | 13 | 0.0002 |
| 3 | Vitamin D2 Analog [EPC] | 1 | 0.0001 |
| 4 | Iron Chelator [EPC] | 4 | 0.0001 |
| 5 | Prostaglandin E1 Analog [EPC] | 2 | 0.0001 |
| 6 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 7 | Sulfone [EPC] | 1 | 0.0001 |
| 8 | Barbiturate [EPC] | 1 | 0.0001 |
| 9 | Vitamin D Analog [EPC] | 1 | 0.0001 |